By Professor Glenda Halliday

Journal articles

McCann H; McGeachie AB; Silberstein P; Lewis SJG; Halliday GM, 2015, 'Restricted disease propagation in multiple system atrophy with prolonged survival', Neuropathology and Applied Neurobiology, 41, pp. 681 - 685, http://dx.doi.org/10.1111/nan.12195

Huang Y; Wang G; Rowe D; Wang Y; Kwok JBJ; Xiao Q; Mastaglia F; Liu J; Chen SD; Halliday G, 2015, 'SNCA gene, but not MAPT, influences onset age of Parkinson's disease in Chinese and Australians', BioMed Research International, 2015, pp. 135674, http://dx.doi.org/10.1155/2015/135674

Tan RH; Devenney E; Kiernan MC; Halliday GM; Hodges JR; Hornberger M, 2015, 'Terra incognita-cerebellar contributions to neuropsychiatric and cognitive dysfunction in behavioral variant frontotemporal dementia', Frontiers in Aging Neuroscience, 7, http://dx.doi.org/10.3389/fnagi.2015.00121

Szeto JYY; O'Callaghan C; Shine JM; Walton CC; Mowszowski L; Naismith SL; Halliday GM; Lewis SJG, 2015, 'The relationships between mild cognitive impairment and phenotype in Parkinson's disease', Parkinson's Disease, 1, http://dx.doi.org/10.1038/npjparkd.2015.15

Chen J; Mills JD; Halliday GM; Janitz M, 2015, 'The role of transcriptional control in multiple system atrophy', Neurobiology of Aging, 36, pp. 394 - 400, http://dx.doi.org/10.1016/j.neurobiolaging.2014.08.015

Sandin L; Nath S; Armstrong A; Janefjord C; McCann H; Halliday GM; Blennow K; Zetterberg H; Brorsson A-C; Kagedal K, 2015, 'P1‐316: The role of lysozyme in Alzheimer's disease', Alzheimer's & Dementia, 11, http://dx.doi.org/10.1016/j.jalz.2015.06.531

Ahmed RM; Paterson RW; Warren JD; Zetterberg H; O'Brien JT; Fox NC; Halliday GM; Schott JM, 2014, 'Biomarkers in dementia: Clinical utility and new directions', Journal of Neurology, Neurosurgery and Psychiatry, 85, pp. 1426 - 1434, http://dx.doi.org/10.1136/jnnp-2014-307662

Stoessl AJ; Halliday GM, 2014, 'DAT-SPECT diagnoses dopamine depletion, but not PD', Movement Disorders, 29, pp. 1705 - 1706, http://dx.doi.org/10.1002/mds.26000

Bras J; Guerreiro R; Darwent L; Parkkinen L; Ansorge O; Escott-Price V; Hernandez DG; Nalls MA; Clark LN; Honig LS; Marder K; Van Der Flier WM; Lemstra A; Scheltens P; Rogaeva E; St George-Hyslop P; Londos E; Zetterberg H; Ortega-Cubero S; Pastor P; Ferman TJ; Graff-Radford NR; Ross OA; Barber I; Braae A; Brown K; Morgan K; Maetzler W; Berg D; Troakes C; Al-Sarraj S; Lashley T; Compta Y; Revesz T; Lees A; Cairns N; Halliday GM; Mann D; Pickering-Brown S; Dickson DW; Singleton A; Hardy J, 2014, 'Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies', Human molecular genetics, 23, pp. 6139 - 6146, http://dx.doi.org/10.1093/hmg/ddu334

Ahmed RM; MacMillan M; Bartley L; Halliday GM; Kiernan MC; Hodges JR; Piguet O, 2014, 'Systemic metabolism in frontotemporal dementia', Neurology, 83, pp. 1812 - 1818, http://dx.doi.org/10.1212/WNL.0000000000000993

Muller AJ; Shine JM; Halliday GM; Lewis SJG, 2014, 'Visual hallucinations in Parkinson's disease: Theoretical models', Movement Disorders, 29, pp. 1591 - 1598, http://dx.doi.org/10.1002/mds.26004

Riley BE; Gardai SJ; Emig-Agius D; Bessarabova M; Ivliev AE; Schüle B; Alexander J; Wallace W; Halliday GM; Langston JW; Braxton S; Yednock T; Shaler T; Johnston JA, 2014, 'Systems-based analyses of brain regions functionally impacted in Parkinson's disease reveals underlying causal mechanisms', PLoS ONE, 9, http://dx.doi.org/10.1371/journal.pone.0102909

Tan RH; Devenney E; Dobson-Stone C; Kwok JB; Hodges JR; Kiernan MC; Halliday GM; Hornberger M, 2014, 'Cerebellar integrity in the amyotrophic lateral sclerosis - Frontotemporal dementia continuum', PLoS ONE, 9, pp. e105632, http://dx.doi.org/10.1371/journal.pone.0105632

Halliday G, 2014, 'Progressive supranuclear palsy finally has a clinically measureable τ abnormality', Journal of Neurology, Neurosurgery and Psychiatry, http://dx.doi.org/10.1136/jnnp-2014-308567

Dzamko N; Zhou J; Huang Y; Halliday GM, 2014, 'Parkinson's disease-implicated kinases in the brain; insights into disease pathogenesis', Frontiers in Molecular Neuroscience, 7, http://dx.doi.org/10.3389/fnmol.2014.00057

Halliday GM; Leverenz JB; Schneider JS; Adler CH, 2014, 'The neurobiological basis of cognitive impairment in Parkinson's disease', Movement Disorders, 29, pp. 634 - 650, http://dx.doi.org/10.1002/mds.25857

Davies KM; Bohic S; Carmona A; Ortega R; Cottam V; Hare DJ; Finberg JPM; Reyes S; Halliday GM; Mercer JFB; Double KL, 2014, 'Copper pathology in vulnerable brain regions in Parkinson's disease', Neurobiology of Aging, 35, pp. 858 - 866, http://dx.doi.org/10.1016/j.neurobiolaging.2013.09.034

Don AS; Hsiao JHT; Bleasel JM; Couttas TA; Halliday GM; Kim WS, 2014, 'Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy', Acta Neuropathologica Communications, 2, http://dx.doi.org/10.1186/s40478-014-0150-6

Murphy KE; Cottle L; Gysbers AM; Cooper AA; Halliday GM, 2014, 'ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with Lewy bodies', Acta Neuropathologica Communications, 2, http://dx.doi.org/10.1186/2051-5960-1-11

Tan RH; Shepherd CE; Kril JJ; McCann H; McGeachie A; McGinley C; Affleck A; Halliday GM, 2014, 'Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43', Acta Neuropathologica Communications, 2, http://dx.doi.org/10.1186/2051-5960-1-33

Bleasel JM; Wong JH; Halliday GM; Kim WS, 2014, 'Lipid dysfunction and pathogenesis of multiple system atrophy', Acta Neuropathologica Communications, 2, http://dx.doi.org/10.1186/2051-5960-2-15

Howitt J; Gysbers AM; Ayton S; Carew-Jones F; Putz U; Finkelstein DI; Halliday GM; Tan SS, 2014, 'Increased Ndfip1 in the substantia nigra of parkinsonian brains is associated with elevated iron levels', PLoS ONE, 9, http://dx.doi.org/10.1371/journal.pone.0087119

Kim WS; Kagedal K; Halliday GM, 2014, 'Alpha-synuclein biology in Lewy body diseases', Alzheimer's Research and Therapy, 6, http://dx.doi.org/10.1186/s13195-014-0073-2

Abbott SK; Li H; Muñoz SS; Knoch B; Batterham M; Murphy KE; Halliday GM; Garner B, 2014, 'Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease', Movement Disorders, 29, pp. 518 - 526, http://dx.doi.org/10.1002/mds.25729

Tan RH; Wong S; Kril JJ; Piguet O; Hornberger M; Hodges JR; Halliday GM, 2014, 'Beyond the temporal pole: Limbic memory circuit in the semantic variant of primary progressive aphasia', Brain, 137, pp. 2065 - 2076, http://dx.doi.org/10.1093/brain/awu118

Mahul-Mellier AL; Fauvet B; Gysbers A; Dikiy I; Oueslati A; Georgeon S; Lamontanara AJ; Bisquertt A; Eliezer D; Masliah E; Halliday G; Hantschel O; Lashuel HA, 2014, 'C-Abl phosphorylates α-synuclein and regulates its degradation: Implication for α-synuclein clearance and contribution to the pathogenesis of parkinson's disease', Human Molecular Genetics, 23, pp. 2858 - 2879, http://dx.doi.org/10.1093/hmg/ddt674

Blennerhassett R; Lillo P; Halliday GM; Hodges JR; Kril JJ, 2014, 'Distribution of pathology in frontal variant Alzheimer's disease', Journal of Alzheimer's Disease, 39, pp. 63 - 70, http://dx.doi.org/10.3233/JAD-131241

Ferrari R; Hernandez DG; Nalls MA; Rohrer JD; Ramasamy A; Kwok JBJ; Dobson-Stone C; Brooks William S BS; Schofield PR; Halliday GM; Hodges JR; Piguet O; Bartley L; Thompson E; Haan E; Hernández I; Ruiz A; Boada M; Borroni B; Padovani A; Cruchaga C; Cairns NJ; Benussi L; Binetti G; Ghidoni R; Forloni G; Galimberti D; Fenoglio C; Serpente M; Scarpini E; Clarimón J; Lleó A; Blesa R; Waldö ML; Nilsson K; Nilsson C; Mackenzie IRA; Hsiung GYR; Mann DMA; Grafman J; Morris CM; Attems J; Griffiths TD; McKeith IG; Thomas AJ; Pietrini P; Huey ED; Wassermann EM; Baborie A; Jaros E; Tierney MC; Pastor P; Razquin C; Ortega-Cubero S; Alonso E; Perneczky R; Diehl-Schmid J; Alexopoulos P; Kurz A; Rainero I; Rubino E; Pinessi L; Rogaeva E; St George-Hyslop P; Rossi G; Tagliavini F; Giaccone G; Rowe JB; Schlachetzki JCM; Uphill J; Collinge J; Mead S; Danek A; Van Deerlin VM; Grossman M; Trojanowski JQ; Van der Zee J; Deschamps W; Van Langenhove T; Cruts M; Van Broeckhoven C; Cappa SF; Le Ber I; Hannequin D; Golfier V; Vercelletto M; Brice A; Nacmias B; Sorbi S; Bagnoli S; Piaceri I; Nielsen JE; Hjermind LE; Riemenschneider M; Mayhaus M; Ibach B; Gasparoni G; Pichler S; Gu W; Rossor MN; Brooks W; Schofield P, 2014, 'Frontotemporal dementia and its subtypes: A genome-wide association study', The Lancet Neurology, 13, pp. 686 - 699, http://dx.doi.org/10.1016/s1474-4422(14)70065-1

Ferrari R; Hernandez DG; Nalls MA; Rohrer JD; Ramasamy A; Kwok JBJ; Dobson-Stone C; Brooks WS; Eld PRS; Halliday GM; Hodges JR; Piguet O; Bartley L; Thompson E; Haan E; Hernandez I; Ruiz A; Boada M; Borroni B; Padovani A; Cruchaga C; Cairns NJ; Benussi L; Binetti G; Ghidoni R; Forloni G; Galimberti D; Fenoglio C; Serpente M; Scarpini E; Clarimon J; Lleo A; Blesa R; Waldoe ML; Nilsson K; Nilsson C; Mackenzie IRA; Hsiung G; Mann DMA; Grafman J; Morris CM; Attems J; Ths TDG; McKeith IG; Thomas AJ; Pietrini P; Huey ED; Wassermann EM; Baborie A; Jaros E; Tierney MC; Pastor P; Razquin C; Ortega-Cubero S; Alonso E; Perneczky R; Diehl-Schmid J; Alexopoulos P; Kurz A; Rubino IRE; Pinessi L; Rogaeva E; St George-Hyslop P; Rossi G; Tagliavini F; Giaccone G; Rowe JB; Schlachetzki JCM; Uphill J; Collinge J; Mead S; Danek A; Van Deerlin VM; Grossman M; Trojanowski JQ; van der Zee J; Deschamps W; Van Langenhove T; Cruts M; Van Broeckhoven C; Cappa SF; Le Ber I; Hannequin D; Golfier V; Vercelletto M; Brice A; Nacmias B; Sorbi S; Bagnoli S; Piaceri I; Nielsen JE; Hjermind LE; Riemenschneider M; Mayhaus M; Ibach B; Gasparoni G; Pichler S; Gu W; Rossor MN; Fox NC; Warren JD; Spillantini MG; Morris HR; Rizzu P; Heutink P; Snowden JS; Rollinson S; Richardson A; Gerhard A; Bruni AC; Maletta R; Frangipane F; Cupidi C; Bernardi L; Anfossi M; Gallo M; Conidi ME; Smirne N; Rademakers R; Baker M; Dickson DW; Graff-Radford NR; Petersen RC; Knopman D; Josephs KA; Boeve BF; Parisi JE; Seeley WW; Miller BL; Karydas AM; Rosen H; van Swieten JC; Dopper EGP; Seelaar H; Pijnenburg YA; Scheltens P; Logroscino G; Capozzo R; Novelli V; Puca AA; Franceschi M; Postiglione A; Milan G; Sorrentino P; Kristiansen M; Chiang HH; Graff C; Pasquier F; Rollin A; Deramecourt V; Lebert F; Kapogiannis D; Ferrucci L; Pickering-Brown S; Hardy J; Momeni P; Singleton AB, 2014, 'Genetic analysis suggests lysosomal and immune system involvement in frontotemporal dementia', JOURNAL OF ALZHEIMERS DISEASE, 41, pp. S25 - S26, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000337049200051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Murphy KE; Halliday GM, 2014, 'Glucocerebrosidase deficits in sporadic Parkinson disease', Autophagy, 10, pp. 1350 - 1351, http://dx.doi.org/10.4161/auto.29074

Hall H; Reyes S; Landeck N; Bye C; Leanza G; Double K; Thompson L; Halliday G; Kirik D, 2014, 'Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease', Brain, 137, pp. 2493 - 2508, http://dx.doi.org/10.1093/brain/awu193

Lam BYK; Halliday GM; Irish M; Hodges JR; Piguet O, 2014, 'Longitudinal white matter changes in frontotemporal dementia subtypes', Human Brain Mapping, 35, pp. 3547 - 3557, http://dx.doi.org/10.1002/hbm.22420

Kordower JH; Halliday G, 2014, 'Misfolded proteins in Huntington disease fetal grafts: Further evidence of cell-to-cell transfer?', Annals of Neurology, 76, pp. 20 - 21, http://dx.doi.org/10.1002/ana.24205

Chare L; Hodges JR; Leyton CE; McGinley C; Tan RH; Kril JJ; Halliday GM, 2014, 'New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications.', Journal of neurology, neurosurgery, and psychiatry, 85, pp. 865 - 870

Kragh CL; Gysbers AM; Rockenstein E; Murphy K; Halliday GM; Masliah E; Jensen PH, 2014, 'Prodegenerative IκBα expression in oligodendroglial α-synuclein models of multiple system atrophy', Neurobiology of Disease, 63, pp. 171 - 183, http://dx.doi.org/10.1016/j.nbd.2013.12.002

Murphy KE; Gysbers AM; Abbott SK; Tayebi N; Kim WS; Sidransky E; Cooper A; Garner B; Halliday GM, 2014, 'Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease', Brain, 137, pp. 834 - 848, http://dx.doi.org/10.1093/brain/awt367

Shine JM; Halliday GM; Gilat M; Matar E; Bolitho SJ; Carlos M; Naismith SL; Lewis SJG, 2014, 'The role of dysfunctional attentional control networks in visual misperceptions in Parkinson's disease', Human Brain Mapping, 35, pp. 2206 - 2219, http://dx.doi.org/10.1002/hbm.22321

Berg D; Postuma RB; Bloem B; Chan P; Dubois B; Gasser T; Goetz CG; Halliday GM; Hardy J; Lang AE; Litvan I; Marek K; Obeso J; Oertel W; Olanow CW; Poewe W; Stern M; Deuschl G, 2014, 'Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease', Movement Disorders, 29, pp. 454 - 462, http://dx.doi.org/10.1002/mds.25844

Gallagher MD; Suh E; Grossman M; Elman L; McCluskey L; Van Swieten JC; Al-Sarraj S; Neumann M; Gelpi E; Ghetti B; Rohrer JD; Halliday G; Van Broeckhoven C; Seilhean D; Shaw PJ; Frosch MP; Alafuzoff I; Antonell A; Bogdanovic N; Brooks W; Cairns NJ; Cooper-Knock J; Cotman C; Cras P; Cruts M; De Deyn PP; Decarli C; Dobson-Stone C; Engelborghs S; Fox N; Galasko D; Gearing M; Gijselinck I; Grafman J; Hartikainen P; Hatanpaa KJ; Highley JR; Hodges J; Hulette C; Ince PG; Jin LW; Kirby J; Kofler J; Kril J; Kwok JBJ; Levey A; Lieberman A; Llado A; Martin JJ; Masliah E; McDermott CJ; McKee A; McLean C; Mead S; Miller CA; Miller J; Munoz DG; Murrell J; Paulson H; Piguet O; Rossor M; Sanchez-Valle R; Sano M; Schneider J; Silbert LC; Spina S; Van Der Zee J; Van Langenhove T; Warren J; Wharton SB; White CL; Woltjer RL; Trojanowski JQ; Lee VMY; Van Deerlin V; Chen-Plotkin AS, 2014, 'TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions', Acta Neuropathologica, 127, pp. 407 - 418, http://dx.doi.org/10.1007/s00401-013-1239-x

Shine JM; O'Callaghan C; Halliday GM; Lewis SJG, 2014, 'Tricks of the mind: Visual hallucinations as disorders of attention', Progress in Neurobiology, 116, pp. 58 - 65, http://dx.doi.org/10.1016/j.pneurobio.2014.01.004

McCann H; Stevens CH; Cartwright H; Halliday GM, 2014, 'α-Synucleinopathy phenotypes', Parkinsonism and Related Disorders, 20, http://dx.doi.org/10.1016/S1353-8020(13)70017-8

Schwartz R; Halliday G; Cordato D; Kril J, 2014, '2.', Journal of Clinical Neuroscience, 21, pp. 2033 - 2033, http://dx.doi.org/10.1016/j.jocn.2014.06.016

Coupland KG; Mellick GD; Silburn PA; Mather K; Armstrong NJ; Sachdev PS; Brodaty H; Huang Y; Halliday GM; Hallupp M; Kim WS; Dobson-Stone C; Kwok JBJ; Kim W; Schofield P, 2014, 'DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E In Vitro', Movement Disorders, 29, pp. 1606 - 1614, http://dx.doi.org/10.1002/mds.25784

Wong JH; Halliday GM; Kim WS, 2014, 'Exploring myelin dysfunction in multiple system atrophy.', Exp Neurobiol, 23, pp. 337 - 344, http://dx.doi.org/10.5607/en.2014.23.4.337

Halliday G, 2014, 'F4‐02‐01: IDENTIFYING THE DYNAMICS OF LEWY BODY FORMATION IN LEWY BODY DISEASES', Alzheimer's & Dementia, 10, http://dx.doi.org/10.1016/j.jalz.2014.04.367

Po K; Leslie FVC; Gracia N; Bartley L; Kwok JBJ; Halliday GM; Hodges JR; Burrell JR, 2014, 'Heritability in frontotemporal dementia: more missing pieces?', Journal of Neurology, 261, pp. 2170 - 2177, http://dx.doi.org/10.1007/s00415-014-7474-9

Coupland K; Kim WS; Halliday G; Dobson‐Stone C; Kwok JBJ, 2014, 'P1‐039: MAPT METHYLATION IN ALZHEIMER'S DISEASE', Alzheimer's & Dementia, 10, http://dx.doi.org/10.1016/j.jalz.2014.05.274

Bleasel JM; Hsiao JHT; Halliday GM; Kim WS, 2013, 'Increased expression of ABCA8 in multiple system atrophy brain is associated with changes in pathogenic proteins', Journal of Parkinson's Disease, 3, pp. 331 - 339, http://dx.doi.org/10.3233/JPD-130203

Cheshire P; Bertram K; Ling H; O'Sullivan SS; Halliday G; McLean C; Bras J; Foltynie T; Storey E; Williams DR, 2013, 'Influence of single nucleotide polymorphisms in COMT, MAO-A and BDNF genes on dyskinesias and levodopa use in Parkinson's disease', Neurodegenerative Diseases, 13, pp. 24 - 28, http://dx.doi.org/10.1159/000351097

Kemp S; Harding AJ; Halliday GM; Mahant N; Fung VSC, 2013, 'Cortical limb myoclonus in pathologically proven progressive supranuclear palsy', Movement Disorders, 28, pp. 1804 - 1806, http://dx.doi.org/10.1002/mds.25693

Back to profile page